Perseverance Asset Management International’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Perseverance Asset Management International’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-36,678	Closed	-$1.74M	–	10
2021 Q4	$1.74M	Sell	36,678 -96,176	-72%	-$5.77M	1.08%	9
2021 Q3	$9.63M	Sell	132,854 -313,120	-70%	-$22.6M	4.53%	6
2021 Q2	$37.4M	Buy	445,974 +109,867	+33%	+$7.25M	12.01%	4
2021 Q1	$16.3M	Buy	336,107 +247,107	+278%	+$13.4M	3.96%	8
2020 Q4	$4.2M	Buy	+89,000	New	+$3.5M	0.99%	12

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perseverance Asset Management International's NBP Position: Q1 2022 in Review

Perseverance Asset Management International sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 36,678 shares — an estimated $1.74M sold.

Perseverance Asset Management International first reported a position in NBP in Q4 2020 and held it in 5 quarters. The position peaked at $37.4M in Q2 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

Perseverance Asset Management International reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Perseverance Asset Management International sold 36,678 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $1.74M.
Perseverance Asset Management International first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 5 quarters.
Perseverance Asset Management International's NovaBridge Biosciences American Depositary Shares position peaked at $37.4M in Q2 2021.
120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on Perseverance Asset Management International's 13F filing for Q1 2022, filed 16 May 2022.